Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
Recruiting · NCT07805356 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism | endocrine system disorder, hypoparathyroidism, parathyroid gland disorder | Recruiting | Phase 3 | 2026-09-16 | NCT07805356 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Calcilytix Therapeutics, Inc., a BridgeBio company | 4 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||